Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.

American journal of hematology - 1 Jul 2004

Fawaz Naglaa A, Bashawery Layla, Al-Sheikh Iman, Qatari Ahlam, Al-Othman Sara S, Almawi Wassim Y

Abstract excerpt

The prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations were investigated among 87 Saudi sickle cell disease (SCD) patients (38 males and 49 females) and 105 healthy controls (65 males and 40 females). The prevalences of factor V Leiden (P = 0.174) and PRT G20210A (P = 0...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to DNA Mutational Analysis
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Homozygote

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Prothrombin

Share to Saudi Arabia

Source

Identifiers

PMID: 15224376
DOI: 10.1002/ajh.20087

Genes

MTHFR
SCD

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15224376-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.PMID 15224376Read ↗

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.Semantic proximity Read ↗

Epidemiology of sickle cell disease in Saudi Arabia.Semantic proximity Read ↗

The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India.Semantic proximity Read ↗

Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations.Semantic proximity Read ↗

Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease.Semantic proximity Read ↗

The Saudi Thrombosis and Familial Thrombophilia Registry. Design, rational, and preliminary results.Semantic proximity Read ↗

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.Semantic proximity Read ↗

Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia.Semantic proximity Read ↗

Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.Semantic proximity Read ↗

Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia.Semantic proximity Read ↗

Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T.Semantic proximity Read ↗

Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.